James River Group Ltd. (JRVR)
NASDAQ: JRVR
· Real-Time Price · USD
5.43
-0.26 (-4.57%)
At close: Sep 05, 2025, 3:59 PM
5.43
0.00%
After-hours: Sep 05, 2025, 04:42 PM EDT
James River Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Excess And Surplus Lines Revenue | 158.32M | 151.54M | 262.02M | 163.49M | 159.57M | 168.92M | 171.19M | 177.03M | 175.52M | 166.65M | 164.09M | 140.95M | 131.66M | 133.39M | 138.41M | 127.6M | 124.02M | 118.8M | 119.95M | 112.8M | 113.34M | 83.83M | 175.76M | 170.73M | 158.57M | 152.44M | 146.64M | 149.81M | 147.01M | 137.33M | 242.16M | 131.03M | 125.48M | 101.09M | 62M | 88.67M | 78.94M | 71.79M | 52.19M | 70.12M | 57.53M | 61.04M |
| Excess And Surplus Lines Revenue Growth | +4.48% | -42.17% | +60.27% | +2.45% | -5.53% | -1.33% | -3.30% | +0.86% | +5.32% | +1.56% | +16.42% | +7.05% | -1.30% | -3.63% | +8.47% | +2.89% | +4.40% | -0.96% | +6.34% | -0.48% | +35.21% | -52.30% | +2.94% | +7.67% | +4.03% | +3.95% | -2.11% | +1.90% | +7.05% | -43.29% | +84.81% | +4.42% | +24.13% | +63.04% | -30.08% | +12.33% | +9.96% | +37.55% | -25.56% | +21.88% | -5.75% | n/a |
| Specialty Admitted Insurance Revenue | 16.17M | 20.1M | 51.52M | 26.42M | 28.05M | 31.54M | 34M | 32.94M | 28.33M | 24.51M | 22.44M | 19.6M | 19.19M | 20.36M | 23.19M | 21.01M | 21.09M | 18.57M | 17.4M | 16.84M | 15.87M | 12.67M | 16.07M | 16.49M | 14.94M | 13.74M | 12.93M | 14.4M | 15.44M | 13.96M | 27.77M | 19.99M | 18.43M | 16.92M | n/a | 13.89M | 13.33M | 12.05M | n/a | 11.46M | 48.84M | 52.15M |
| Specialty Admitted Insurance Revenue Growth | -19.56% | -60.99% | +94.98% | -5.82% | -11.04% | -7.24% | +3.22% | +16.27% | +15.59% | +9.22% | +14.48% | +2.16% | -5.78% | -12.18% | +10.37% | -0.40% | +13.62% | +6.67% | +3.33% | +6.13% | +25.23% | -21.15% | -2.55% | +10.39% | +8.77% | +6.27% | -10.24% | -6.71% | +10.61% | -49.76% | +38.93% | +8.45% | +8.93% | n/a | n/a | +4.21% | +10.64% | n/a | -100.00% | -76.53% | -6.34% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 161.3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 13.12M | n/a | n/a | n/a | 11.76M | n/a | n/a | n/a | 12.63M | n/a | n/a | n/a | 12.38M | n/a | n/a | n/a | -54.78M | n/a | n/a | 54.78M | 7.69M | n/a | n/a | n/a | 5.49M | n/a | n/a | n/a | 4.01M | n/a | n/a | n/a |
| Selling, General, and Administrative Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | -100.00% | +612.58% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |